Industry Research Reports
Global Heparin Market Insights, Forecast to 2031
Industry: Pharma & Healthcare
Published Date: 2025-05-07
Pages: 150 Pages
Report ld: 4725917
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Heparin Market Size(US$)
CAGR 2025-2031
7.8%
Market Size,2031
USD 3,083
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,966 million
Market Forecast in 2031(Value)
US$ 3,083 million
CAGR
7.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Heparin market is projected to grow from US$ 1966 million in 2025 to US$ 3083 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The heparin API market is primarily driven by the rising global prevalence of cardiovascular and thromboembolic diseases, along with increasing surgical procedures. Growing aging populations and higher obesity rates contribute to sustained demand for anticoagulants. Additionally, heparin's use in treating COVID-19-associated thrombotic complications has further propelled market expansion. Pharmaceutical industry advancements in emerging markets (e.g., China and India) and the biopharmaceutical sector's demand for high-quality heparin also fuel market growth.
Key trends in the heparin API market include: 1) a technological shift from animal-sourced heparin (porcine intestinal mucosa extraction) to synthetic alternatives (e.g., low-molecular-weight heparin); 2) stringent regulatory requirements for supply chain traceability and quality control; 3) intensified competition from biosimilars, driving process optimization and cost reduction; and 4) the rise of local pharmaceutical players in emerging markets, diversifying the global heparin supply chain.
In terms of consumption side, this report focuses on the sales of Heparin by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Heparin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Heparin, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Heparin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Heparin sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Heparin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Heparin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc.
MARKET SEGMENTATION
By Company
- Shenzhen Hepalink Pharmaceutical
- Yantai Dongcheng Pharmaceutical
- Pfizer
- Bioibérica
- Changzhou Qianhong Biopharma
- Nanjing King-friend Biochemical Pharmaceutical
- Hebei Changshan Biochemical Pharmaceutical
- Qingdao Jiulong Biopharmaceutical
- Opocrin
- Dongying Tiandong Pharmaceutical
- Aspen Oss
- Yino Pharma
- Nanjing Xinbai Pharmaceutical
- Hubei Enoray Biopharmaceutical
- Cisen Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Heparin Sodium
- Heparin Calcium
Segment by Application
- UFH
- LMWH
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heparin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heparin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Market by Application
1.3.1 Global Heparin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
1.3.2 UFH
1.3.3 LMWH
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Heparin Revenue Estimates and Forecasts 2020-2031
2.2 Global Revenue by Region
2.2.1 Global Heparin Revenue by Region: 2020 VS 2024 VS 2031
2.2.2 Global Heparin Revenue by Region (2020-2031)
2.2.3 Global Heparin Revenue Market Share by Region (2020-2031)
2.3 Global Heparin Sales Estimates and Forecasts 2020-2031
2.4 Global Sales by Region
2.4.1 Global Heparin Sales by Region: 2020 VS 2024 VS 2031
2.4.2 Global Heparin Sales by Region (2020-2031)
2.4.3 Global Heparin Sales Market Share by Region (2020-2031)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Sales by Manufacturers
3.1.1 Global Heparin Sales by Manufacturers (2020-2025)
3.1.2 Global Heparin Sales Market Share by Manufacturers (2020-2025)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Heparin in 2024
3.2 Global Revenue by Manufacturers
3.2.1 Global Heparin Revenue by Manufacturers (2020-2025)
3.2.2 Global Heparin Revenue Market Share by Manufacturers (2020-2025)
3.2.3 Global Top 10 and Top 5 Companies by Heparin Revenue in 2024
3.3 Global Key Players of Heparin, Industry Ranking, 2023 VS 2024
3.4 Global Heparin Sales Price by Manufacturers (2020-2025)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Heparin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Heparin, Product Offered and Application
3.8 Global Key Manufacturers of Heparin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sales by Type
4.1.1 Global Heparin Historical Sales by Type (2020-2025)
4.1.2 Global Heparin Forecasted Sales by Type (2026-2031)
4.1.3 Global Heparin Sales Market Share by Type (2020-2031)
4.2 Global Revenue by Type
4.2.1 Global Heparin Historical Revenue by Type (2020-2025)
4.2.2 Global Heparin Forecasted Revenue by Type (2026-2031)
4.2.3 Global Heparin Revenue Market Share by Type (2020-2031)
4.3 Global Price by Type
4.3.1 Global Heparin Price by Type (2020-2025)
4.3.2 Global Heparin Price Forecast by Type (2026-2031)
5 Market Size by Application
5.1 Global Sales by Application
5.1.1 Global Heparin Historical Sales by Application (2020-2025)
5.1.2 Global Heparin Forecasted Sales by Application (2026-2031)
5.1.3 Global Heparin Sales Market Share by Application (2020-2031)
5.2 Global Revenue by Application
5.2.1 Global Heparin Historical Revenue by Application (2020-2025)
5.2.2 Global Heparin Forecasted Revenue by Application (2026-2031)
5.2.3 Global Heparin Revenue Market Share by Application (2020-2031)
5.3 Global Price by Application
5.3.1 Global Heparin Price by Application (2020-2025)
5.3.2 Global Heparin Price Forecast by Application (2026-2031)
6 US & Canada
6.1 US & Canada Market Size by Type
6.1.1 US & Canada Heparin Sales by Type (2020-2031)
6.1.2 US & Canada Heparin Revenue by Type (2020-2031)
6.2 US & Canada Market Size by Application
6.2.1 US & Canada Heparin Sales by Application (2020-2031)
6.2.2 US & Canada Heparin Revenue by Application (2020-2031)
6.3 US & Canada Market Size by Country
6.3.1 US & Canada Heparin Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 US & Canada Heparin Revenue by Country (2020-2031)
6.3.3 US & Canada Heparin Sales by Country (2020-2031)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Market Size by Type
7.1.1 Europe Heparin Sales by Type (2020-2031)
7.1.2 Europe Heparin Revenue by Type (2020-2031)
7.2 Europe Market Size by Application
7.2.1 Europe Heparin Sales by Application (2020-2031)
7.2.2 Europe Heparin Revenue by Application (2020-2031)
7.3 Europe Market Size by Country
7.3.1 Europe Heparin Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 Europe Heparin Sales by Country (2020-2031)
7.3.3 Europe Heparin Revenue by Country (2020-2031)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Market Size by Type
8.1.1 China Heparin Sales by Type (2020-2031)
8.1.2 China Heparin Revenue by Type (2020-2031)
8.2 China Market Size by Application
8.2.1 China Heparin Sales by Application (2020-2031)
8.2.2 China Heparin Revenue by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Market Size by Type
9.1.1 Asia Heparin Sales by Type (2020-2031)
9.1.2 Asia Heparin Revenue by Type (2020-2031)
9.2 Asia Market Size by Application
9.2.1 Asia Heparin Sales by Application (2020-2031)
9.2.2 Asia Heparin Revenue by Application (2020-2031)
9.3 Asia Market Size by Region
9.3.1 Asia Heparin Revenue by Region: 2020 VS 2024 VS 2031
9.3.2 Asia Heparin Revenue by Region (2020-2031)
9.3.3 Asia Heparin Sales by Region (2020-2031)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Market Size by Type
10.1.1 Middle East, Africa and Latin America Heparin Sales by Type (2020-2031)
10.1.2 Middle East, Africa and Latin America Heparin Revenue by Type (2020-2031)
10.2 Middle East, Africa and Latin America Market Size by Application
10.2.1 Middle East, Africa and Latin America Heparin Sales by Application (2020-2031)
10.2.2 Middle East, Africa and Latin America Heparin Revenue by Application (2020-2031)
10.3 Middle East, Africa and Latin America Market Size by Country
10.3.1 Middle East, Africa and Latin America Heparin Revenue by Country: 2020 VS 2024 VS 2031
10.3.2 Middle East, Africa and Latin America Heparin Revenue by Country (2020-2031)
10.3.3 Middle East, Africa and Latin America Heparin Sales by Country (2020-2031)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Shenzhen Hepalink Pharmaceutical
11.1.1 Shenzhen Hepalink Pharmaceutical Company Information
11.1.2 Shenzhen Hepalink Pharmaceutical Overview
11.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.4 Shenzhen Hepalink Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments
11.2 Yantai Dongcheng Pharmaceutical
11.2.1 Yantai Dongcheng Pharmaceutical Company Information
11.2.2 Yantai Dongcheng Pharmaceutical Overview
11.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.4 Yantai Dongcheng Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yantai Dongcheng Pharmaceutical Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.4 Pfizer Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Bioibérica
11.4.1 Bioibérica Company Information
11.4.2 Bioibérica Overview
11.4.3 Bioibérica Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.4 Bioibérica Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bioibérica Recent Developments
11.5 Changzhou Qianhong Biopharma
11.5.1 Changzhou Qianhong Biopharma Company Information
11.5.2 Changzhou Qianhong Biopharma Overview
11.5.3 Changzhou Qianhong Biopharma Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.4 Changzhou Qianhong Biopharma Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Changzhou Qianhong Biopharma Recent Developments
11.6 Nanjing King-friend Biochemical Pharmaceutical
11.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
11.6.2 Nanjing King-friend Biochemical Pharmaceutical Overview
11.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
11.7 Hebei Changshan Biochemical Pharmaceutical
11.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
11.7.2 Hebei Changshan Biochemical Pharmaceutical Overview
11.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
11.8 Qingdao Jiulong Biopharmaceutical
11.8.1 Qingdao Jiulong Biopharmaceutical Company Information
11.8.2 Qingdao Jiulong Biopharmaceutical Overview
11.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.4 Qingdao Jiulong Biopharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments
11.9 Opocrin
11.9.1 Opocrin Company Information
11.9.2 Opocrin Overview
11.9.3 Opocrin Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.4 Opocrin Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Opocrin Recent Developments
11.10 Dongying Tiandong Pharmaceutical
11.10.1 Dongying Tiandong Pharmaceutical Company Information
11.10.2 Dongying Tiandong Pharmaceutical Overview
11.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.4 Dongying Tiandong Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dongying Tiandong Pharmaceutical Recent Developments
11.11 Aspen Oss
11.11.1 Aspen Oss Company Information
11.11.2 Aspen Oss Overview
11.11.3 Aspen Oss Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.4 Aspen Oss Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aspen Oss Recent Developments
11.12 Yino Pharma
11.12.1 Yino Pharma Company Information
11.12.2 Yino Pharma Overview
11.12.3 Yino Pharma Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.4 Yino Pharma Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Yino Pharma Recent Developments
11.13 Nanjing Xinbai Pharmaceutical
11.13.1 Nanjing Xinbai Pharmaceutical Company Information
11.13.2 Nanjing Xinbai Pharmaceutical Overview
11.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.4 Nanjing Xinbai Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Nanjing Xinbai Pharmaceutical Recent Developments
11.14 Hubei Enoray Biopharmaceutical
11.14.1 Hubei Enoray Biopharmaceutical Company Information
11.14.2 Hubei Enoray Biopharmaceutical Overview
11.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.4 Hubei Enoray Biopharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hubei Enoray Biopharmaceutical Recent Developments
11.15 Cisen Pharmaceutical
11.15.1 Cisen Pharmaceutical Company Information
11.15.2 Cisen Pharmaceutical Overview
11.15.3 Cisen Pharmaceutical Heparin Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.4 Cisen Pharmaceutical Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Cisen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Heparin Industry Chain Analysis
12.2 Heparin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Heparin Production Mode & Process
12.4 Heparin Sales and Marketing
12.4.1 Heparin Sales Channels
12.4.2 Heparin Distributors
12.5 Heparin Customers
13 Heparin Market Dynamics
13.1 Heparin Industry Trends
13.2 Heparin Market Drivers
13.3 Heparin Market Challenges
13.4 Heparin Market Restraints
14 Key Findings in the Global Heparin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Heparin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Major Manufacturers of Heparin Sodium
Table 3. Major Manufacturers of Heparin Calcium
Table 4. Global Heparin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 5. Global Heparin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 6. Global Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Revenue Market Share by Region (2020-2031)
Table 8. Global Heparin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (billion units)
Table 9. Global Heparin Sales by Region (2020-2031) & (billion units)
Table 10. Global Sales Market Share by Region (2020-2031)
Table 11. Global Heparin Sales by Manufacturers (2020-2025) & (billion units)
Table 12. Global Heparin Sales Share by Manufacturers (2020-2025)
Table 13. Global Heparin Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 14. Global Heparin Revenue Market Share by Manufacturers (2020-2025)
Table 15. Global Key Players of Heparin, Industry Ranking, 2023 VS 2024 VS 2024
Table 16. Heparin Price by Manufacturers (2020-2025) & (US$/billion units)
Table 17. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 19. Global Key Manufacturers of Heparin, Manufacturing Base Distribution and Headquarters
Table 20. Global Key Manufacturers of Heparin, Product Offered and Application
Table 21. Global Key Manufacturers of Heparin, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Heparin Sales by Type (2020-2025) & (billion units)
Table 24. Global Heparin Sales by Type (2026-2031) & (billion units)
Table 25. Global Sales Share by Type (2020-2031)
Table 26. Global Heparin Revenue by Type (2020-2025) & (US$ Million)
Table 27. Global Heparin Revenue by Type (2026-2031) & (US$ Million)
Table 28. Global Revenue Share by Type (2020-2031)
Table 29. Heparin Price by Type (2020-2025) & (US$/billion units)
Table 30. Global Heparin Price Forecast by Type (2026-2031) & (US$/billion units)
Table 31. Global Heparin Sales by Application (2020-2025) & (billion units)
Table 32. Global Heparin Sales by Application (2026-2031) & (billion units)
Table 33. Global Sales Share by Application (2020-2031)
Table 34. Global Heparin Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Heparin Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Revenue Share by Application (2020-2031)
Table 37. Heparin Price by Application (2020-2025) & (US$/billion units)
Table 38. Global Heparin Price Forecast by Application (2026-2031) & (US$/billion units)
Table 39. US & Canada Sales by Type (2020-2031) & (billion units)
Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)
Table 41. US & Canada Sales by Application (2020-2031) & (billion units)
Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)
Table 43. US & Canada Heparin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)
Table 45. US & Canada Sales by Country (2020-2031) & (billion units)
Table 46. Europe Sales by Type (2020-2031) & (billion units)
Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)
Table 48. Europe Sales by Application (2020-2031) & (billion units)
Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)
Table 50. Europe Heparin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 51. Europe Sales by Country (2020-2031) & (billion units)
Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)
Table 53. China Sales by Type (2020-2031) & (billion units)
Table 54. China Revenue by Type (2020-2031) & (US$ Million)
Table 55. China Sales by Application (2020-2031) & (billion units)
Table 56. China Revenue by Application (2020-2031) & (US$ Million)
Table 57. Asia Sales by Type (2020-2031) & (billion units)
Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)
Table 59. Asia Sales by Application (2020-2031) & (billion units)
Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)
Table 61. Asia Heparin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)
Table 63. Asia Sales by Region (2020-2031) & (billion units)
Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (billion units)
Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (billion units)
Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
Table 68. Middle East, Africa and Latin America Heparin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (billion units)
Table 71. Shenzhen Hepalink Pharmaceutical Company Information
Table 72. Shenzhen Hepalink Pharmaceutical Description and Major Businesses
Table 73. Shenzhen Hepalink Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 74. Shenzhen Hepalink Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 75. Shenzhen Hepalink Pharmaceutical Recent Developments
Table 76. Yantai Dongcheng Pharmaceutical Company Information
Table 77. Yantai Dongcheng Pharmaceutical Description and Major Businesses
Table 78. Yantai Dongcheng Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 79. Yantai Dongcheng Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 80. Yantai Dongcheng Pharmaceutical Recent Developments
Table 81. Pfizer Company Information
Table 82. Pfizer Description and Major Businesses
Table 83. Pfizer Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 84. Pfizer Product Model Numbers, Pictures, Descriptions and Specifications
Table 85. Pfizer Recent Developments
Table 86. Bioibérica Company Information
Table 87. Bioibérica Description and Major Businesses
Table 88. Bioibérica Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 89. Bioibérica Product Model Numbers, Pictures, Descriptions and Specifications
Table 90. Bioibérica Recent Developments
Table 91. Changzhou Qianhong Biopharma Company Information
Table 92. Changzhou Qianhong Biopharma Description and Major Businesses
Table 93. Changzhou Qianhong Biopharma Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 94. Changzhou Qianhong Biopharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 95. Changzhou Qianhong Biopharma Recent Developments
Table 96. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 97. Nanjing King-friend Biochemical Pharmaceutical Description and Major Businesses
Table 98. Nanjing King-friend Biochemical Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 99. Nanjing King-friend Biochemical Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 100. Nanjing King-friend Biochemical Pharmaceutical Recent Developments
Table 101. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 102. Hebei Changshan Biochemical Pharmaceutical Description and Major Businesses
Table 103. Hebei Changshan Biochemical Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 104. Hebei Changshan Biochemical Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 105. Hebei Changshan Biochemical Pharmaceutical Recent Developments
Table 106. Qingdao Jiulong Biopharmaceutical Company Information
Table 107. Qingdao Jiulong Biopharmaceutical Description and Major Businesses
Table 108. Qingdao Jiulong Biopharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 109. Qingdao Jiulong Biopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Qingdao Jiulong Biopharmaceutical Recent Developments
Table 111. Opocrin Company Information
Table 112. Opocrin Description and Major Businesses
Table 113. Opocrin Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 114. Opocrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Opocrin Recent Developments
Table 116. Dongying Tiandong Pharmaceutical Company Information
Table 117. Dongying Tiandong Pharmaceutical Description and Major Businesses
Table 118. Dongying Tiandong Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 119. Dongying Tiandong Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Dongying Tiandong Pharmaceutical Recent Developments
Table 121. Aspen Oss Company Information
Table 122. Aspen Oss Description and Major Businesses
Table 123. Aspen Oss Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 124. Aspen Oss Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Aspen Oss Recent Developments
Table 126. Yino Pharma Company Information
Table 127. Yino Pharma Description and Major Businesses
Table 128. Yino Pharma Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 129. Yino Pharma Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Yino Pharma Recent Developments
Table 131. Nanjing Xinbai Pharmaceutical Company Information
Table 132. Nanjing Xinbai Pharmaceutical Description and Major Businesses
Table 133. Nanjing Xinbai Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 134. Nanjing Xinbai Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Nanjing Xinbai Pharmaceutical Recent Developments
Table 136. Hubei Enoray Biopharmaceutical Company Information
Table 137. Hubei Enoray Biopharmaceutical Description and Major Businesses
Table 138. Hubei Enoray Biopharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 139. Hubei Enoray Biopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Hubei Enoray Biopharmaceutical Recent Developments
Table 141. Cisen Pharmaceutical Company Information
Table 142. Cisen Pharmaceutical Description and Major Businesses
Table 143. Cisen Pharmaceutical Sales (billion units), Revenue (US$ Million), Price (US$/billion units) and Gross Margin (2020-2025)
Table 144. Cisen Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Cisen Pharmaceutical Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Distributors List
Table 149. Customers List
Table 150. Market Trends
Table 151. Market Drivers
Table 152. Market Challenges
Table 153. Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Heparin Market Share by Type: 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Global Heparin Market Share by Application: 2024 & 2031
Figure 8. UFH
Figure 9. LMWH
Figure 10. Heparin Report Years Considered
Figure 11. Global Heparin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Heparin Revenue (2020-2031) & (US$ Million)
Figure 13. Global Heparin Revenue by Region (2020-2031) (US$ Million)
Figure 14. Global Heparin Revenue Market Share by Region in Percentage: 2024 Versus 2031
Figure 15. Global Heparin Revenue Market Share by Region (2020-2031)
Figure 16. Global Heparin Sales (2020-2031) & (billion units)
Figure 17. Global Heparin Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (billion units)
Figure 18. Global Heparin Sales Market Share by Region (2020-2031)
Figure 19. US & Canada Heparin Sales YoY (2020-2031) & (billion units)
Figure 20. US & Canada Heparin Revenue YoY (2020-2031) & (US$ Million)
Figure 21. Europe Heparin Sales YoY (2020-2031) & (billion units)
Figure 22. Europe Heparin Revenue YoY (2020-2031) & (US$ Million)
Figure 23. China Heparin Sales YoY (2020-2031) & (billion units)
Figure 24. China Heparin Revenue YoY (2020-2031) & (US$ Million)
Figure 25. Asia (excluding China) Heparin Sales YoY (2020-2031) & (billion units)
Figure 26. Asia (excluding China) Heparin Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Heparin Sales YoY (2020-2031) & (billion units)
Figure 28. Middle East, Africa and Latin America Heparin Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Global Heparin Sales Share by Manufacturers (2024)
Figure 30. The Heparin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 31. Global Heparin Revenue Share by Manufacturers (2024)
Figure 32. The Top 5 and 10 Largest Manufacturers of Heparin in the World: Market Share by Heparin Revenue in 2024
Figure 33. Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Global Heparin Sales Market Share by Type (2020-2031)
Figure 35. Global Heparin Revenue Market Share by Type (2020-2031)
Figure 36. Global Heparin Sales Market Share by Application (2020-2031)
Figure 37. Global Heparin Revenue Market Share by Application (2020-2031)
Figure 38. US & Canada Heparin Sales Market Share by Type (2020-2031)
Figure 39. US & Canada Heparin Revenue Market Share by Type (2020-2031)
Figure 40. US & Canada Heparin Sales Market Share by Application (2020-2031)
Figure 41. US & Canada Heparin Revenue Market Share by Application (2020-2031)
Figure 42. US & Canada Heparin Revenue Share by Country (2020-2031)
Figure 43. US & Canada Heparin Sales Share by Country (2020-2031)
Figure 44. US Heparin Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Heparin Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Heparin Sales Market Share by Type (2020-2031)
Figure 47. Europe Heparin Revenue Market Share by Type (2020-2031)
Figure 48. Europe Heparin Sales Market Share by Application (2020-2031)
Figure 49. Europe Heparin Revenue Market Share by Application (2020-2031)
Figure 50. Europe Heparin Sales Share by Country (2020-2031)
Figure 51. Europe Heparin Revenue Share by Country (2020-2031)
Figure 52. Germany Heparin Revenue (2020-2031) & (US$ Million)
Figure 53. France Heparin Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Heparin Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Heparin Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Heparin Revenue (2020-2031) & (US$ Million)
Figure 57. China Heparin Sales Market Share by Type (2020-2031)
Figure 58. China Heparin Revenue Market Share by Type (2020-2031)
Figure 59. China Heparin Sales Market Share by Application (2020-2031)
Figure 60. China Heparin Revenue Market Share by Application (2020-2031)
Figure 61. Asia Heparin Sales Market Share by Type (2020-2031)
Figure 62. Asia Heparin Revenue Market Share by Type (2020-2031)
Figure 63. Asia Heparin Sales Market Share by Application (2020-2031)
Figure 64. Asia Heparin Revenue Market Share by Application (2020-2031)
Figure 65. Asia Heparin Revenue Share by Region (2020-2031)
Figure 66. Asia Heparin Sales Share by Region (2020-2031)
Figure 67. Japan Heparin Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Heparin Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Heparin Revenue (2020-2031) & (US$ Million)
Figure 70. Southeast Asia Heparin Revenue (2020-2031) & (US$ Million)
Figure 71. India Heparin Revenue (2020-2031) & (US$ Million)
Figure 72. Australia Heparin Revenue (2020-2031) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Heparin Sales Market Share by Type (2020-2031)
Figure 74. Middle East, Africa and Latin America Heparin Revenue Market Share by Type (2020-2031)
Figure 75. Middle East, Africa and Latin America Heparin Sales Market Share by Application (2020-2031)
Figure 76. Middle East, Africa and Latin America Heparin Revenue Market Share by Application (2020-2031)
Figure 77. Middle East, Africa and Latin America Heparin Revenue Share by Country (2020-2031)
Figure 78. Middle East, Africa and Latin America Heparin Sales Share by Country (2020-2031)
Figure 79. Brazil Heparin Revenue (2020-2031) & (US$ Million)
Figure 80. Mexico Heparin Revenue (2020-2031) & (US$ Million)
Figure 81. Turkey Heparin Revenue (2020-2031) & (US$ Million)
Figure 82. Israel Heparin Revenue (2020-2031) & (US$ Million)
Figure 83. GCC Countries Heparin Revenue (2020-2031) & (US$ Million)
Figure 84. Value Chain
Figure 85. Heparin Production Process
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Heparin market?
The top companies in the global Heparin market are Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Pfizer.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Heparin market size from 2025 to 2031?
What was the global market size of Heparin in 2031?
What was the global market size of Heparin in 2025?
Related Reports
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin market size was US$ 1469 million in 2025 and is forecast to reach a readjusted size of US$ 2462 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 92
USD 4250.00
(Single User License)
Global Heparin Market Research Report 2026
The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 121
USD 2900.00
(Single User License)
Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin was estimated to be worth US$ 1469 million in 2025 and is projected to reach US$ 2462 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 130
USD 3950.00
(Single User License)
Global Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin market is projected to grow from US$ 1225 million in 2024 to US$ 2301 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 166
USD 4900.00
(Single User License)
Heparin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 113
USD 3950.00
(Single User License)
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin market size was US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 93
USD 4250.00
(Single User License)
Global Heparin Market Research Report 2025
The global market for Heparin was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-08-27
Pages: 91
USD 2900.00
(Single User License)
Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 147
USD 5900.00
(Single User License)
Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 2134 million in 2024 and is forecast to a readjusted size of US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 130
USD 3950.00
(Single User License)
Global Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin market size was US$ 1469 million in 2025 and is forecast to reach a readjusted size of US$ 2462 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 92
USD 4250.00 (Single User License)Global Heparin Market Research Report 2026
The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 121
USD 2900.00 (Single User License)Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin was estimated to be worth US$ 1469 million in 2025 and is projected to reach US$ 2462 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 130
USD 3950.00 (Single User License)Global Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin market is projected to grow from US$ 1225 million in 2024 to US$ 2301 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 166
USD 4900.00 (Single User License)Heparin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 113
USD 3950.00 (Single User License)Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin market size was US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 93
USD 4250.00 (Single User License)Global Heparin Market Research Report 2025
The global market for Heparin was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-08-27
Pages: 91
USD 2900.00 (Single User License)Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 147
USD 5900.00 (Single User License)Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 2134 million in 2024 and is forecast to a readjusted size of US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 130
USD 3950.00 (Single User License)Global Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now